Compare MODD & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MODD | PLSM |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | Israel |
| Employees | N/A | 63 |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.5M | 25.0M |
| IPO Year | 2019 | N/A |
| Metric | MODD | PLSM |
|---|---|---|
| Price | $4.59 | $6.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 39.1K | ★ 1.8M |
| Earning Date | 02-17-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.62 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $3.00 |
| 52 Week High | $6.16 | $12.97 |
| Indicator | MODD | PLSM |
|---|---|---|
| Relative Strength Index (RSI) | 50.83 | 69.23 |
| Support Level | $4.31 | $3.49 |
| Resistance Level | $5.80 | $6.64 |
| Average True Range (ATR) | 0.78 | 0.88 |
| MACD | -0.09 | 0.22 |
| Stochastic Oscillator | 33.78 | 27.69 |
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.